|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 3.900 USD | -1.02% |
|
-3.23% | -60.24% |
| 25-03-19 | Kalaris Therapeutics Completes Merger with AlloVir | MT |
| 25-03-17 | AlloVir, Inc.(NasdaqCM:ALVR) dropped from NASDAQ Composite Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 49.21M | - | - | - | - | - |
- Stock Market
- Stocks
- ALVR Stock
- Charts ALLOVIRPAR
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
